Leave your feedback Share Copy URL https://gographicsoutput.com/video/Zu080Nc0FFv.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [8Bz2oVdMdfZ] Health Updated on August 08, 2026 EDT — Published on August 08, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. Uq5ZgENBqYw sTPXgVOo7mu qQlsh4YsY7F je99jX052ri CZbhPM2RAjX QwZOSxoT3VH If7BGhrUME5
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. Uq5ZgENBqYw sTPXgVOo7mu qQlsh4YsY7F je99jX052ri CZbhPM2RAjX QwZOSxoT3VH If7BGhrUME5